• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肺移植术后闭塞性细支气管炎中的淋巴细胞亚群分布

Lymphocyte subset populations in bronchiolitis obliterans after heart-lung transplantation.

作者信息

Holland V A, Cagle P T, Windsor N T, Noon G P, Greenberg S D, Lawrence E C

机构信息

Rockwell-McKelvey Pulmonary Immunology Laboratory, Baylor College of Medicine, Houston, Texas.

出版信息

Transplantation. 1990 Dec;50(6):955-9. doi: 10.1097/00007890-199012000-00011.

DOI:10.1097/00007890-199012000-00011
PMID:2124009
Abstract

The long-term success of heart-lung transplantation is limited by the development of bronchiolitis obliterans, possibly as a form of chronic lung allograft rejection. In the present study, we have characterized by immunohistochemical staining the lymphocytes infiltrating the lesions of bronchiolitis obliterans in one patient following heart-lung transplantation. The finding that the preponderant cells expressed the CD8 (putative cytotoxic/suppressor) marker lends support to the notion that chronic rejection is at least one mechanism for the development of bronchiolotis obliterans following heart-lung transplantation.

摘要

心肺移植的长期成功受到闭塞性细支气管炎发展的限制,闭塞性细支气管炎可能是慢性肺移植排斥反应的一种形式。在本研究中,我们通过免疫组织化学染色对一名心肺移植患者闭塞性细支气管炎病变中浸润的淋巴细胞进行了特征分析。优势细胞表达CD8(假定的细胞毒性/抑制性)标志物这一发现支持了以下观点,即慢性排斥反应至少是心肺移植后闭塞性细支气管炎发生的一种机制。

相似文献

1
Lymphocyte subset populations in bronchiolitis obliterans after heart-lung transplantation.心肺移植术后闭塞性细支气管炎中的淋巴细胞亚群分布
Transplantation. 1990 Dec;50(6):955-9. doi: 10.1097/00007890-199012000-00011.
2
Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.急性和慢性肺移植排斥反应中的支气管肺泡灌洗液体特征
J Heart Lung Transplant. 2004 May;23(5):532-40. doi: 10.1016/j.healun.2003.07.004.
3
[Graft dysfunction, acute rejection and bronchiolitis obliterans in lung and heart-lung transplantation].[肺与心肺移植中的移植物功能障碍、急性排斥反应和闭塞性细支气管炎]
Rev Mal Respir. 1996 Nov;13(5 Suppl):S31-40.
4
Lung T-Cell Profile Alterations are Associated with Bronchiolitis Obliterans Syndrome in Cystic Fibrosis Lung Transplant Recipients.肺 T 细胞特征改变与囊性纤维化肺移植受者的细支气管炎性闭塞综合征相关。
Lung. 2020 Feb;198(1):157-161. doi: 10.1007/s00408-019-00298-1. Epub 2019 Dec 5.
5
Bronchiolitis obliterans following heart-lung and lung transplantation.
Respir Med. 1994 Jan;88(1):9-15. doi: 10.1016/0954-6111(94)90167-8.
6
Longitudinal comparisons of lymphocytes and subtypes between airway wall and bronchoalveolar lavage after human lung transplantation.人肺移植后气道壁与支气管肺泡灌洗之间淋巴细胞及其亚群的纵向比较。
Transplantation. 2005 Jul 27;80(2):185-92. doi: 10.1097/01.tp.0000165091.31541.23.
7
Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.一组肺移植受者的支气管肺泡灌洗细胞因子谱:白细胞介素-12对闭塞性细支气管炎综合征发病的预测作用。
J Heart Lung Transplant. 2004 Sep;23(9):1053-60. doi: 10.1016/j.healun.2003.08.019.
8
Preferential production of IgG2 antibodies by parenchymal lung B-lymphocytes during lung allograft rejection.
Transplant Proc. 1997 May;29(3):1891-5. doi: 10.1016/s0041-1345(97)00109-7.
9
Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.肺移植后闭塞性细支气管炎综合征发生的危险因素。
J Thorac Cardiovasc Surg. 1997 Aug;114(2):195-202. doi: 10.1016/S0022-5223(97)70144-2.
10
Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection.慢性肺移植排斥反应中II类主要组织相容性复合体抗原(HLA-DR)的表达及淋巴细胞亚群免疫分型
Arch Pathol Lab Med. 1995 May;119(5):432-9.

引用本文的文献

1
Primary human adult lung epithelial cells in vitro: response to interferon-gamma and cytomegalovirus.体外培养的原代成人肺上皮细胞:对γ干扰素和巨细胞病毒的反应
Immunology. 1993 May;79(1):119-24.